Ananda Developments (AQSE:ANA) EBIT : £-1.67 Mil (TTM As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments EBIT?

Ananda Developments's earnings before interest and taxes (EBIT) for the six months ended in Jul. 2023 was £-0.95 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jul. 2023 was £-1.67 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ananda Developments's annualized ROC % for the quarter that ended in Jul. 2023 was -20.90%. Ananda Developments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2023 was -110.33%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ananda Developments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2023 was -25.82%.

Ananda Developments EBIT Historical Data

The historical data trend for Ananda Developments's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments EBIT Chart

Ananda Developments Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

EBIT

-0.37

-0.38

-0.50

-0.97

-1.05

Ananda Developments Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
EBIT	Get a 7-Day Free Trial						-0.69	-0.28	-0.33	-0.72	-0.95

Competitive Comparison of Ananda Developments's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ananda Developments's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ananda Developments's EV-to-EBIT falls into.

Ananda Developments EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jul. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-1.67 Mil.

Ananda Developments (AQSE:ANA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ananda Developments's annualized ROC % for the quarter that ended in Jul. 2023 is calculated as:

	ROC % (Q: Jul. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jan. 2023 )	+	Invested Capital (Q: Jul. 2023 ))	/ count )
=	-1.89 * ( 1 - 0% )	/	( (10.598	+	7.492)	/ 2 )
=	-1.89	/	9.045
=	-20.90 %

where

	Invested Capital		(Q: Jan. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6.509	-	0.146	-	( 0.019	-	max(0, 4.511	-	0.276	+	0.019	))
=	10.598

	Invested Capital		(Q: Jul. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	7.772	-	2.136	-	( 0.012	-	max(0, 2.136	-	0.28	+	0.012	))
=	7.492

Note: The Operating Income data used here is two times the semi-annual (Jul. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Ananda Developments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jul. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jan. 2023		Q: Jul. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.89	/	( ( (1.762 + max(-0.751, 0))	+	(1.664 + max(-1.868, 0)) )	/	2 )
=	-1.89	/	( ( 1.762	+	1.664 )	/	2 )
=	-1.89	/	1.713
=	-110.33 %

where Working Capital is:

	Working Capital		(Q: Jan. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.077)	-	(0.146	+	0	+	0.682)
=	-0.751

	Working Capital		(Q: Jul. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.222	+	0	+	0.046)	-	(2.136	+	0	+	0)
=	-1.868

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jul. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ananda Developments's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jul. 2023 )
	=	-1.667	/	6.455
	=	-25.82 %

Ananda Developments EBIT Related Terms

Thank you for viewing the detailed overview of Ananda Developments's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Developments (AQSE:ANA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

1FX:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

http://www.anandadevelopments.com

Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines